Genzyme Corp. (NSDQ:GENZ) closed the divestiture of its genetic testing unit, Genzyme Genetics.
The Cambridge, Mass.-based biotech’s reproductive and oncology testing services business was bought by Laboratory Corporation of America Holdings (NYSE:LH).